Immunic Inc.

NASDAQ: IMUX
Share price (3/28/25): $1.20
Market cap (3/28/25): $108 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration – amended

Prospectus supplement

Shelf registration – amended

Ownership Filter

Janus Henderson Group plc

Avidity Partners Management LP

Adage Capital Management, L.P.

Vanguard Group Inc

News Filter

Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing

Other Events, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC